InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
M-TriDAP | Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response... | 2016 | PLoS One | Yang Q. et al. | DOI: 10.1371/journal.pone.0162179 |
MDP | Triggering of NOD2 Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monoc... | 2017 | Cell Rep. | Lessard A.J. et al. | DOI: 10.1016/j.celrep.2017.08.009 |
Blasticidin | Mitotic progression following DNA damage enables pattern recognition within m... | 2017 | Nature. | Harding S.M. et al. | DOI: 10.1038/nature23470 |
LTA-SA | The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated in... | 2015 | Nat Med. | Youm Y.H. et al. | DOI: 10.1038/nm.3804 |
EndoFit™ OVA protein | A novel antigen delivery system induces strong humoral and CTL immune responses. | 2017 | Biomaterials. | Yang Z. et al. | DOI: 10.1016/j.biomaterials.2017.04.035 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | T(H)17 cells promote microbial killing and innate immune sensing of DNA via i... | 2015 | Nat Immunol. | Meller S. et al. | DOI: 10.1038/ni.3211 |
TLR7-HA | Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinol... | 2011 | J. Immunol. | Kuznik A. et al. | DOI: 10.4049/jimmunol.1000702 |
MyD88 | Toll/Interleukin-1 Receptor Domain Dimers as the Platform for Activation and ... | 2012 | J Biol Chem. | Fekonja O. et al | DOI: 10.1074/jbc.M112.376186 |
DNA synthesis inhibitor | Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosupp... | 2014 | Cancer Cell. | Özdemir B.C. et al. | DOI: 10.1016/j.ccr.2014.04.005 |
HEK-Blue™ Null1 Cells | Short single-stranded DNA degradation products augment the activation of Toll... | 2017 | Nat Commun. | Pohar J. et al. | DOI: 10.1038/ncomms15363 |
LPS-EK (LPS from E. coli K12) | Analysis of single-cell cytokine secretion reveals a role for paracrine signa... | 2015 | Sci Signal. | Xue Q. et al. | DOI: 10.1126/scisignal.aaa2155 |
Plasmocin® - Mycoplasma Elimination Reagent | Fast transdifferentiation of human Wharton's jelly mesenchymal stem cells int... | 2017 | J Neurosci Methods. | Bonilla-Porras A.R. et al. | DOI: 10.1016/j.jneumeth.2017.03.005 |
ODN 1668 - TLR9 ligand | VISA is required for B cell expression of TLR7. | 2012 | J. Immunol. | Xu L.G. et al. | DOI: 10.4049/jimmunol.1100918 |
Pam3CSK4 | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen... | 2017 | Sci Rep. | Madan-Lala R. et al. | DOI: 10.1038/s41598-017-02804-y |
Peptide M / Agarose | Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce su... | 2014 | J Immunol. | Recke A. et al. | DOI: 10.4049/jimmunol.1400160 |
2'3'-cGAMP VacciGrade™ | The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively ac... | 2015 | Elife | Blaauboer S.M. et al. | DOI: 10.7554/eLife.06670 |
Loxoribine | TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Aut... | 2017 | J Immunol. | Ye J. et al. | DOI: 10.4049/jimmunol.1601890 |
CL429 | Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine i... | 2014 | J Immunol. | Pavot V. et al. | DOI: 10.4049/jimmunol.1402184 |
293/NOD1 | Identification of Selective Small Molecule Inhibitors of the Nucleotide-Bindi... | 2014 | PLoS One | Rickard D.J. et al. | DOI: 10.1371/journal.pone.0096737 |
pFUSE-hIgG1-Fc | Targeting aggressive prostate cancer-associated CD44v6 using phage display se... | 2017 | Oncotarget. | Peng Y. et al. | DOI: 10.18632/oncotarget.21421 |